TY - JOUR AU - Menon, M. P. AU - Pittaluga, S. AU - Jaffe, E. S. PY - 2012 DA - 2012// TI - The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification JO - Cancer J VL - 18 UR - https://doi.org/10.1097/PPO.0b013e31826aee97 DO - 10.1097/PPO.0b013e31826aee97 ID - Menon2012 ER - TY - JOUR AU - Boyle, J. AU - Beaven, A. W. AU - Diehl, L. F. AU - Prosnitz, L. R. AU - Kelsey, C. R. PY - 2014 DA - 2014// TI - Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy JO - Oncology (Williston Park). VL - 28 ID - Boyle2014 ER - TY - JOUR AU - Tilly, H. AU - Vitolo, U. AU - Walewski, J. AU - Silva, M. G. AU - Shpilberg, O. AU - Andre, M. PY - 2012 DA - 2012// TI - Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up JO - Ann Oncol. VL - 23 UR - https://doi.org/10.1093/annonc/mds273 DO - 10.1093/annonc/mds273 ID - Tilly2012 ER - TY - JOUR AU - Gisselbrecht, C. AU - Glass, B. AU - Mounier, N. AU - Singh Gill, D. AU - Linch, D. C. AU - Trneny, M. PY - 2010 DA - 2010// TI - Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.1618 DO - 10.1200/JCO.2010.28.1618 ID - Gisselbrecht2010 ER - TY - JOUR AU - Awan, F. T. AU - Lapalombella, R. AU - Trotta, R. AU - Butchar, J. P. AU - Yu, B. AU - Benson, D. M. PY - 2010 DA - 2010// TI - CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-06-229039 DO - 10.1182/blood-2009-06-229039 ID - Awan2010 ER - TY - JOUR AU - Horton, H. M. AU - Bernett, M. J. AU - Pong, E. AU - Peipp, M. AU - Karki, S. AU - Chu, S. Y. PY - 2008 DA - 2008// TI - Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-2268 DO - 10.1158/0008-5472.CAN-08-2268 ID - Horton2008 ER - TY - JOUR AU - Woyach, J. A. AU - Awan, F. AU - Flinn, I. W. AU - Berdeja, J. G. AU - Wiley, E. AU - Mansoor, S. PY - 2014 DA - 2014// TI - A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-08-593269 DO - 10.1182/blood-2014-08-593269 ID - Woyach2014 ER - TY - JOUR AU - Abramson, J. S. PY - 2006 DA - 2006// TI - T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management JO - Oncologist VL - 11 UR - https://doi.org/10.1634/theoncologist.11-4-384 DO - 10.1634/theoncologist.11-4-384 ID - Abramson2006 ER - TY - STD TI - A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987–94. doi:10.1056/NEJM199309303291402 ID - ref9 ER - TY - JOUR AU - Fisher, R. I. AU - Gaynor, E. R. AU - Dahlberg, S. AU - Oken, M. M. AU - Grogan, T. M. AU - Mize, E. M. PY - 1993 DA - 1993// TI - Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma JO - N Engl J Med VL - 328 UR - https://doi.org/10.1056/NEJM199304083281404 DO - 10.1056/NEJM199304083281404 ID - Fisher1993 ER - TY - JOUR AU - Coiffier, B. AU - Lepage, E. AU - Briere, J. AU - Herbrecht, R. AU - Tilly, H. AU - Bouabdallah, R. PY - 2002 DA - 2002// TI - CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011795 DO - 10.1056/NEJMoa011795 ID - Coiffier2002 ER - TY - JOUR AU - Vellenga, E. AU - Putten, W. L. AU - van ‘t Veer, M. B. AU - Zijlstra, J. M. AU - Fibbe, W. E. AU - Oers, M. H. PY - 2008 DA - 2008// TI - Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-08-108415 DO - 10.1182/blood-2007-08-108415 ID - Vellenga2008 ER - TY - JOUR AU - Blay, J. AU - Gomez, F. AU - Sebban, C. AU - Bachelot, T. AU - Biron, P. AU - Guglielmi, C. PY - 1998 DA - 1998// TI - The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial JO - Parma Group. Blood. VL - 92 ID - Blay1998 ER - TY - JOUR AU - Thieblemont, C. AU - Briere, J. AU - Mounier, N. AU - Voelker, H. U. AU - Cuccuini, W. AU - Hirchaud, E. PY - 2011 DA - 2011// TI - The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.4423 DO - 10.1200/JCO.2011.35.4423 ID - Thieblemont2011 ER - TY - JOUR AU - Hammer, O. PY - 2012 DA - 2012// TI - CD19 as an attractive target for antibody-based therapy JO - MAbs VL - 4 UR - https://doi.org/10.4161/mabs.21338 DO - 10.4161/mabs.21338 ID - Hammer2012 ER - TY - JOUR AU - Jurczak, W. AU - Zinzani, P. AU - Goy, A. AU - Provencio, M. AU - Nagy, Z. AU - Robak, T. PY - 2015 DA - 2015// TI - Phase IIa study of single-agent MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL) JO - J Clin Oncol. VL - 33 ID - Jurczak2015 ER - TY - JOUR AU - Hallek, M. AU - Cheson, B. D. AU - Catovsky, D. AU - Caligaris-Cappio, F. AU - Dighiero, G. AU - Dohner, H. PY - 2008 DA - 2008// TI - Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-06-093906 DO - 10.1182/blood-2007-06-093906 ID - Hallek2008 ER -